CAXTON CORP - AGILE THERAPEUTICS INC ownership

AGILE THERAPEUTICS INC's ticker is AGRX and the CUSIP is 00847L100. A total of 51 filers reported holding AGILE THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
CAXTON CORP ownership history of AGILE THERAPEUTICS INC
ValueSharesWeighting
Q1 2018$4,664,000
-4.7%
1,814,949
-0.3%
5.06%
-15.0%
Q4 2017$4,896,000
-39.7%
1,820,0120.0%5.95%
-28.0%
Q3 2017$8,117,000
+33.3%
1,820,012
+12.1%
8.26%
-13.0%
Q2 2017$6,088,000
+17.0%
1,623,5670.0%9.50%
-36.1%
Q1 2017$5,204,000
-57.0%
1,623,567
-23.5%
14.86%
-64.0%
Q4 2016$12,104,000
-2.3%
2,123,567
+19.7%
41.30%
-25.5%
Q3 2016$12,385,000
+3.0%
1,774,319
+12.3%
55.46%
+308.7%
Q2 2016$12,028,000
+35.6%
1,580,491
+10.6%
13.57%
+10.8%
Q1 2016$8,873,000
+3843.6%
1,428,871
+6103.0%
12.24%
+1197.1%
Q4 2015$225,000
+45.2%
23,0350.0%0.94%
+351.7%
Q3 2015$155,000
+2.6%
23,035
+31.2%
0.21%
+30.6%
Q2 2015$151,000
-39.1%
17,559
-34.3%
0.16%
-45.9%
Q1 2015$248,000
+36.3%
26,736
-9.8%
0.30%
+41.6%
Q4 2014$182,000
-9.0%
29,645
+8.1%
0.21%
+1.5%
Q3 2014$200,000
-7.8%
27,415
+10.1%
0.21%
+23.4%
Q2 2014$217,00024,9110.17%
Other shareholders
AGILE THERAPEUTICS INC shareholders Q3 2015
NameSharesValueWeighting ↓
Perceptive Advisors 31,839,850$42,348,0000.28%
NEEDHAM INVESTMENT MANAGEMENT LLC 735,000$978,0000.14%
INVESTOR AB 3,510,189$4,669,0000.14%
Tibra Equities Europe Ltd 241,100$321,0000.10%
FIRST MIDWEST BANK TRUST DIVISION 349,158$464,0000.06%
GSA CAPITAL PARTNERS LLP 372,543$495,0000.06%
DUMONT & BLAKE INVESTMENT ADVISORS LLC 110,000$146,0000.04%
Kalos Management, Inc. 19,250$24,0000.01%
Summit Global Investments 110,100$146,0000.01%
Founders Capital Management 10,000$13,0000.01%
View complete list of AGILE THERAPEUTICS INC shareholders